Literature DB >> 25916247

Evaluating a counselling strategy for diagnostic WES in paediatric neurology: an exploration of parents' information and communication needs.

L Krabbenborg1, J Schieving2, T Kleefstra3, L E L M Vissers3, M A Willemsen2, J A Veltman3, S van der Burg1.   

Abstract

As whole exome sequencing (WES) is just starting to be used as a diagnostic tool in paediatric neurology for children with a neurological disorder, and patient experiences and preferences with regard to counselling are relatively underexplored. This article explores experiences and preferences of parents with pre-test and post-test counselling in a trial that uses WES for diagnostics. Second, it maps information and communication needs which exceed the counselling protocol, in order to acquire insight into how it can be improved. Data were gathered through in-depth interviews with parents of 15 children who were included in the trial. Information and communication needs of parents differed from the protocol with respect to (i) the type and amount of information provided about WES research, (ii) incidental findings, (iii) communication about progress of the study, and (iv) the communication of the results. Furthermore, parents preferred to have more of a communicative exchange with health care providers about their daily struggles and concerns related to their life with a diseased child and wanted to know how a diagnosis could offer help. There are different ways to meet parental needs, but we suggest that assigning a case manager might be a helpful option that deserves further exploration.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  clinical care; genetic counselling; next generation sequencing; paediatric neurology; parents' experiences; whole exome sequencing

Mesh:

Year:  2015        PMID: 25916247     DOI: 10.1111/cge.12601

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  11 in total

1.  Incidental or secondary findings: an integrative and patient-inclusive approach to the current debate.

Authors:  Marlies Saelaert; Heidi Mertes; Elfride De Baere; Ignaas Devisch
Journal:  Eur J Hum Genet       Date:  2018-07-03       Impact factor: 4.246

2.  Much ado about nothing: A qualitative study of the experiences of an average-risk population receiving results of exome sequencing.

Authors:  Shannon Rego; Orit Dagan-Rosenfeld; Stephanie A Bivona; Michael P Snyder; Kelly E Ormond
Journal:  J Genet Couns       Date:  2019-03-05       Impact factor: 2.537

3.  Genetic Counseling in the Era of Genomics: What's all the Fuss about?

Authors:  Gemma R Brett; Ella J Wilkins; Emma T Creed; Kirsty West; Anna Jarmolowicz; Giulia M Valente; Yael Prawer; Elly Lynch; Ivan Macciocca
Journal:  J Genet Couns       Date:  2018-01-24       Impact factor: 2.537

4.  Not the End of the Odyssey: Parental Perceptions of Whole Exome Sequencing (WES) in Pediatric Undiagnosed Disorders.

Authors:  Allyn McConkie Rosell; Loren D M Pena; Kelly Schoch; Rebecca Spillmann; Jennifer Sullivan; Stephen R Hooper; Yong-Hui Jiang; Nicolas Mathey-Andrews; David B Goldstein; Vandana Shashi
Journal:  J Genet Couns       Date:  2016-02-12       Impact factor: 2.537

5.  How do providers discuss the results of pediatric exome sequencing with families?

Authors:  Sarah A Walser; Allison Werner-Lin; Rebecca Mueller; Victoria A Miller; Sawona Biswas; Barbara A Bernhardt
Journal:  Per Med       Date:  2017-09-04       Impact factor: 2.512

6.  Challenges to informed consent for exome sequencing: A best-worst scaling experiment.

Authors:  Rachel H Gore; John F P Bridges; Julie S Cohen; Barbara B Biesecker
Journal:  J Genet Couns       Date:  2019-09-25       Impact factor: 2.717

7.  A clinical utility study of exome sequencing versus conventional genetic testing in pediatric neurology.

Authors:  Lisenka E L M Vissers; Kirsten J M van Nimwegen; Jolanda H Schieving; Erik-Jan Kamsteeg; Tjitske Kleefstra; Helger G Yntema; Rolph Pfundt; Gert Jan van der Wilt; Lotte Krabbenborg; Han G Brunner; Simone van der Burg; Janneke Grutters; Joris A Veltman; Michèl A A P Willemsen
Journal:  Genet Med       Date:  2017-03-23       Impact factor: 8.822

8.  Incidence and phenotypes of childhood-onset genetic epilepsies: a prospective population-based national cohort.

Authors:  Joseph D Symonds; Sameer M Zuberi; Kirsty Stewart; Ailsa McLellan; Mary O'Regan; Stewart MacLeod; Alice Jollands; Shelagh Joss; Martin Kirkpatrick; Andreas Brunklaus; Daniela T Pilz; Jay Shetty; Liam Dorris; Ishaq Abu-Arafeh; Jamie Andrew; Philip Brink; Mary Callaghan; Jamie Cruden; Louise A Diver; Christine Findlay; Sarah Gardiner; Rosemary Grattan; Bethan Lang; Jane MacDonnell; Jean McKnight; Calum A Morrison; Lesley Nairn; Meghan M Slean; Elma Stephen; Alan Webb; Angela Vincent; Margaret Wilson
Journal:  Brain       Date:  2019-08-01       Impact factor: 13.501

9.  Understanding the Psychosocial Effects of WES Test Results on Parents of Children with Rare Diseases.

Authors:  Lotte Krabbenborg; L E L M Vissers; J Schieving; T Kleefstra; E J Kamsteeg; J A Veltman; M A Willemsen; S Van der Burg
Journal:  J Genet Couns       Date:  2016-04-20       Impact factor: 2.537

Review 10.  Utility of Genetic Testing from the Perspective of Parents/Caregivers: A Scoping Review.

Authors:  Robin Z Hayeems; Stephanie Luca; Daniel Assamad; Ayushi Bhatt; Wendy J Ungar
Journal:  Children (Basel)       Date:  2021-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.